Abstract

Protein interaction is critical molecular regulatory activity underlining cellular functions and precise cell fate choices. Using TWIST1 BioID-proximity-labelling and network propagation analyses, we discovered and characterized a TWIST-chromatin regulatory module (TWIST1-CRM) in the neural crest cells (NCC). Combinatorial perturbation of core members of TWIST1-CRM: TWIST1, CHD7, CHD8, and WHSC1 in cell models and mouse embryos revealed that loss of the function of the regulatory module resulted in abnormal differentiation of NCCs and compromised craniofacial tissue patterning. Following NCC delamination, low level of TWIST1-CRM activity is instrumental to stabilize the early NCC signatures and migratory potential by repressing the neural stem cell programs. High level of TWIST1 module activity at later phases commits the cells to the ectomesenchyme. Our study further revealed the functional interdependency of TWIST1 and potential neurocristopathy factors in NCC development.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files. Sequencing data have been deposited in GEO under accession codes GSE130251. External data analyzed has been listed in Supplementary File 6.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Xiaochen Fan

    Embryology, CMRI, The University of Sydney, Sydney, Australia
    For correspondence
    x6fan@eng.ucsd.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4316-0616
  2. V Pragathi Masamsetti

    Embryology Unit, CMRI, The University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  3. Jane QJ Sun

    Embryology Unit, CMRI, The University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  4. Kasper Engholm-Keller

    Synapse Proteomics Group, CMRI, The University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Pierre Osteil

    Embryology Unit, CMRI, The University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  6. Joshua Studdert

    Embryology Unit, CMRI, The University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  7. Mark E Graham

    Synapse Proteomics, CMRI, The University of Sydney, Westmead, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7290-1217
  8. Nicolas Fossat

    Embryology Unit, CMRI, The University of Sydney, Sydney, Australia
    For correspondence
    nfossat@sund.ku.dk
    Competing interests
    The authors declare that no competing interests exist.
  9. Patrick PL Tam

    Embryology Unit, CMRI, The University of Sydney, Westmead, Australia
    For correspondence
    PTam@cmri.org.au
    Competing interests
    The authors declare that no competing interests exist.

Funding

National Health and Medical Research Council (1066832,1079160,1003100,1110751)

  • Mark E Graham
  • Patrick PL Tam

Australian Research Council (1094008)

  • Xiaochen Fan
  • Patrick PL Tam

University of Sydney

  • Xiaochen Fan

Children's Medical Research Institute

  • Xiaochen Fan
  • Pierre Osteil
  • Nicolas Fossat

Carlsbergfondet (CF15-1056,CF16-0066)

  • Kasper Engholm-Keller

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Animal experimentations were performed in compliance with animal ethics and welfare guidelines stipulated by the Children's Medical Research Institute/Children's Hospital at Westmead Animal Ethics Committee, protocol number C230.

Copyright

© 2021, Fan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,239
    views
  • 511
    downloads
  • 37
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Xiaochen Fan
  2. V Pragathi Masamsetti
  3. Jane QJ Sun
  4. Kasper Engholm-Keller
  5. Pierre Osteil
  6. Joshua Studdert
  7. Mark E Graham
  8. Nicolas Fossat
  9. Patrick PL Tam
(2021)
TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation
eLife 10:e62873.
https://doi.org/10.7554/eLife.62873

Share this article

https://doi.org/10.7554/eLife.62873

Further reading

    1. Cell Biology
    2. Genetics and Genomics
    Keva Li, Nicholas Tolman ... UK Biobank Eye and Vision Consortium
    Research Article

    A glaucoma polygenic risk score (PRS) can effectively identify disease risk, but some individuals with high PRS do not develop glaucoma. Factors contributing to this resilience remain unclear. Using 4,658 glaucoma cases and 113,040 controls in a cross-sectional study of the UK Biobank, we investigated whether plasma metabolites enhanced glaucoma prediction and if a metabolomic signature of resilience in high-genetic-risk individuals existed. Logistic regression models incorporating 168 NMR-based metabolites into PRS-based glaucoma assessments were developed, with multiple comparison corrections applied. While metabolites weakly predicted glaucoma (Area Under the Curve = 0.579), they offered marginal prediction improvement in PRS-only-based models (p=0.004). We identified a metabolomic signature associated with resilience in the top glaucoma PRS decile, with elevated glycolysis-related metabolites—lactate (p=8.8E-12), pyruvate (p=1.9E-10), and citrate (p=0.02)—linked to reduced glaucoma prevalence. These metabolites combined significantly modified the PRS-glaucoma relationship (Pinteraction = 0.011). Higher total resilience metabolite levels within the highest PRS quartile corresponded to lower glaucoma prevalence (Odds Ratiohighest vs. lowest total resilience metabolite quartile=0.71, 95% Confidence Interval = 0.64–0.80). As pyruvate is a foundational metabolite linking glycolysis to tricarboxylic acid cycle metabolism and ATP generation, we pursued experimental validation for this putative resilience biomarker in a human-relevant Mus musculus glaucoma model. Dietary pyruvate mitigated elevated intraocular pressure (p=0.002) and optic nerve damage (p<0.0003) in Lmx1bV265D mice. These findings highlight the protective role of pyruvate-related metabolism against glaucoma and suggest potential avenues for therapeutic intervention.

    1. Cell Biology
    Affiong Ika Oqua, Kin Chao ... Alejandra Tomas
    Research Article

    G protein-coupled receptors (GPCRs) are integral membrane proteins which closely interact with their plasma membrane lipid microenvironment. Cholesterol is a lipid enriched at the plasma membrane with pivotal roles in the control of membrane fluidity and maintenance of membrane microarchitecture, directly impacting on GPCR stability, dynamics, and function. Cholesterol extraction from pancreatic beta cells has previously been shown to disrupt the internalisation, clustering, and cAMP responses of the glucagon-like peptide-1 receptor (GLP-1R), a class B1 GPCR with key roles in the control of blood glucose levels via the potentiation of insulin secretion in beta cells and weight reduction via the modulation of brain appetite control centres. Here, we unveil the detrimental effect of a high cholesterol diet on GLP-1R-dependent glucoregulation in vivo, and the improvement in GLP-1R function that a reduction in cholesterol synthesis using simvastatin exerts in pancreatic islets. We next identify and map sites of cholesterol high occupancy and residence time on active vs inactive GLP-1Rs using coarse-grained molecular dynamics (cgMD) simulations, followed by a screen of key residues selected from these sites and detailed analyses of the effects of mutating one of these, Val229, to alanine on GLP-1R-cholesterol interactions, plasma membrane behaviours, clustering, trafficking and signalling in INS-1 832/3 rat pancreatic beta cells and primary mouse islets, unveiling an improved insulin secretion profile for the V229A mutant receptor. This study (1) highlights the role of cholesterol in regulating GLP-1R responses in vivo; (2) provides a detailed map of GLP-1R - cholesterol binding sites in model membranes; (3) validates their functional relevance in beta cells; and (4) highlights their potential as locations for the rational design of novel allosteric modulators with the capacity to fine-tune GLP-1R responses.